Edition:
United States

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

7.95USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$7.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
558,670
52-wk High
$15.95
52-wk Low
$3.41

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 2.26
Market Cap(Mil.): $688.81
Shares Outstanding(Mil.): 87.97
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 109.48 62.40
EPS (TTM): -2.30 -- --
ROI: -303.86 7.96 11.78
ROE: -381.16 8.11 12.61

Earnings vs. Estimates